September, historically the worst month of the year for stocks, once again brought pain to Wall Street, sending the market lower for the third quarter. A steep rise in Treasury yields and oil prices, combined with fears that the Federal Reserve would keep interest rates "higher for longer," weighed on stocks over the past four weeks or so.
This picture shows an unit dedicated to the production of insulin pens at the factory of the US pharmaceutical company Eli Lilly in Fegersheim, eastern France.September, historically the worst month of the year for stocks, once again brought pain to Wall Street, sending the market lower for the third quarter.